rs17466502
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012307.5(EPB41L3):c.1507-806T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,282 control chromosomes in the GnomAD database, including 1,273 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1273 hom., cov: 32)
Consequence
EPB41L3
NM_012307.5 intron
NM_012307.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.20
Publications
4 publications found
Genes affected
EPB41L3 (HGNC:3380): (erythrocyte membrane protein band 4.1 like 3) Predicted to enable cytoskeletal protein-membrane anchor activity. Predicted to be a structural constituent of cytoskeleton. Predicted to be involved in several processes, including nervous system development; paranodal junction maintenance; and protein localization to paranode region of axon. Located in cell-cell junction and plasma membrane. Biomarker of meningioma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EPB41L3 | NM_012307.5 | c.1507-806T>G | intron_variant | Intron 12 of 22 | ENST00000341928.7 | NP_036439.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPB41L3 | ENST00000341928.7 | c.1507-806T>G | intron_variant | Intron 12 of 22 | 1 | NM_012307.5 | ENSP00000343158.2 |
Frequencies
GnomAD3 genomes AF: 0.121 AC: 18416AN: 152164Hom.: 1277 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18416
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.121 AC: 18402AN: 152282Hom.: 1273 Cov.: 32 AF XY: 0.119 AC XY: 8874AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
18402
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
8874
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
2278
AN:
41550
American (AMR)
AF:
AC:
2352
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
635
AN:
3472
East Asian (EAS)
AF:
AC:
585
AN:
5188
South Asian (SAS)
AF:
AC:
583
AN:
4826
European-Finnish (FIN)
AF:
AC:
1339
AN:
10602
Middle Eastern (MID)
AF:
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10168
AN:
68030
Other (OTH)
AF:
AC:
279
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
840
1680
2520
3360
4200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
408
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.